Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Heartburn”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00242736
What this trial is testing

An Open-Label Study of Once-Daily Oral Administration of Esomeprazole 40 mg in Patients With Symptoms of Gastroesophageal Reflux Disease (GERD)

Who this might be right for
GERD
AstraZeneca 350
Testing effectiveness (Phase 2)Study completedNCT05556824
What this trial is testing

Multi-Center Study of Panosyl-Isomaltooligosaccharides Adjunctive to PPI Therapy to Treat GERD

Who this might be right for
Gastroesophageal Reflux
Microbiome Health Sciences 255
Large-scale testing (Phase 3)Study completedNCT01869491
What this trial is testing

Compound Sodium Alginate Double Action Chewable Tablet Symptomatic Relief Study

Who this might be right for
Gastroesophageal Reflux DiseaseDyspepsia
Reckitt Benckiser Healthcare (UK) Limited 1,107
Not applicableUnknownNCT01128608
What this trial is testing

The Effect of High PCO2 Solution on Esophageal Acid Sensation

Who this might be right for
Gastroesophageal Reflux Disease
Southern Arizona VA Health Care System 20
Large-scale testing (Phase 3)Study completedNCT00255190
What this trial is testing

Safety and Quality of Life Study of Dexlansoprazole Modified Release Formulation to Treat Heartburn

Who this might be right for
Gastroesophageal Reflux Disease
Takeda 591
Not applicableStudy completedNCT07563790
What this trial is testing

A Pre-market, Two-stages Interventional Clinical Investigation to Evaluate the Safety and the Performance of Fibroin Syrup in Reducing the Gastroesophageal Reflux Disease (GERD) Symptomatology in Nonerosive Reflux Disease (NERD) Patients

Who this might be right for
GERD (Heartburn, Regurgitation, and Dyspepsia)Gastroesophageal Reflux (GERD)
Rose Pharma SA 47
Large-scale testing (Phase 3)Study completedNCT00847808
What this trial is testing

Efficacy of Dexlansoprazole MR on Heartburn Control in Participants Previously Receiving Twice Daily Proton Pump Inhibitor Therapy

Who this might be right for
Gastroesophageal Reflux
Takeda 178
Large-scale testing (Phase 3)Study completedNCT00171483
What this trial is testing

Assessment of the Role of Tegaserod Therapy in the Management of Gastroesophageal Reflux Disease (GERD) Symptoms in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs).

Who this might be right for
Gastroesophageal Reflux Disease (GERD)
Novartis 30
Large-scale testing (Phase 3)Study completedNCT01065649
What this trial is testing

Effect of Nortriptyline in Cortical Representation of Heartburn in Nonerosive Reflux Disease (NERD) Patients

Who this might be right for
Gastroesophageal Reflux Disease
Universidade de Passo Fundo 20
Early research (Phase 1)Study completedNCT00818870
What this trial is testing

Effect of Vecam 40/300 and Vecam 20/300 Compared to Omeprazole 20 mg on Gastric pH

Who this might be right for
Gastroesophageal Reflux
Vecta Ltd. 60
Not applicableStudy completedNCT01647958
What this trial is testing

The EndoGastric Solutions TEMPO Trial

Who this might be right for
Gastroesophageal Reflux Disease (GERD)
EndoGastric Solutions 65
Post-approval studies (Phase 4)Study completedNCT04309916
What this trial is testing

Study to Evaluate the Efficacy and Safety of Tegoprazan in ERD Patients With Nighttime Heartburn and Sleep Disturbance

Who this might be right for
Erosive Reflux Disease
HK inno.N Corporation 46
Large-scale testing (Phase 3)Study completedNCT00251758
What this trial is testing

Safety and Efficacy of Dexlansoprazole Modified Release Formulation to Treat Heartburn

Who this might be right for
Gastroesophageal Reflux Disease
Takeda 908
Post-approval studies (Phase 4)UnknownNCT02105090
What this trial is testing

Efficacy Study of Articaine Lozenge to Enhance the Procedural Compliance of the Adults Undergoing Gastroduodenoscopy

Who this might be right for
DyspepsiaHematemesisAbdominal Pain+1 more
Helsinki University Central Hospital 120
Not applicableUnknownNCT05382169
What this trial is testing

Prevalence of Mast Cell Activation Syndrome in Patients With EDS With Digestive Disorders

Who this might be right for
Ehlers Danlos Hypermobile Syndrome
Lille Catholic University 30
Post-approval studies (Phase 4)UnknownNCT03860012
What this trial is testing

Folic Acid in Pediatric Inflammatory Bowel Disease

Who this might be right for
Inflammatory Bowel Diseases
Le Bonheur Children's Hospital 100
Large-scale testing (Phase 3)Study completedNCT02873689
What this trial is testing

Efficacy and Safety of Dexlansoprazole on Heartburn Relief in Chinese Patients

Who this might be right for
HeartburnGastroesophageal Reflux Disease
Takeda 217
Testing effectiveness (Phase 2)Study completedNCT01642602
What this trial is testing

Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules in Treating Symptomatic Non-Erosive Gastroesophageal Reflux Disease in Adolescents

Who this might be right for
Gastroesophageal Reflux Disease
Takeda 104
Large-scale testing (Phase 3)Study completedNCT00251745
What this trial is testing

Efficacy and Safety of Dexlansoprazole Modified Release Formulation to Treat Heartburn

Who this might be right for
Gastroesophageal Reflux Disease
Takeda 908
Large-scale testing (Phase 3)Study completedNCT06217393
What this trial is testing

Trial of Itopride 150mg Once a Day Versus Itopride 50 mg Thrice a Day; in Patients With Functional Dyspepsia

Who this might be right for
Functional Dyspepsia
Abbott 564
Next Page